marketcap
Facebook
Twitter
Telegram
Report an ErrorTaiwan Liposome Company, Ltd. Financial Statements 2011-2024 | TLC
Annual Financial Statements Taiwan Liposome Company, Ltd.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
156 M | 165 M | 208 M | - | - | - | - | - | - | - |
Shares |
32.9 M | 32.9 M | 31.6 M | - | - | - | - | - | - | - |
Net Income |
-983 M | -808 M | -902 M | -874 M | -824 M | -676 M | -633 M | -401 M | -187 M | -217 M |
Revenue |
102 M | 209 M | 62.3 M | 49.6 M | 41.7 M | 59.8 M | 95.9 M | 159 M | 241 M | 78.2 M |
EBITDA |
-955 M | -737 M | -844 M | -846 M | -761 M | -652 M | -620 M | -380 M | -164 M | -202 M |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
146 M | 166 M | 148 M | 135 M | 141 M | 138 M | 103 M | 98.1 M | 55.9 M | 46 M |
All numbers in USD currency